Cargando…
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
Somatostatin receptor (SSTR) agonist tracers used in nuclear medicine scans are classically used for neuroendocrine tumor diagnosis and staging. SSTR are however, expressed more widely in a variety of cells as seen in the distribution of physiological tracer uptake during whole body scans. This prov...
Autores principales: | Helgebostad, Rasmus, Revheim, Mona-Elisabeth, Johnsrud, Kjersti, Amlie, Kristine, Alavi, Abass, Connelly, James Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870812/ https://www.ncbi.nlm.nih.gov/pubmed/35204618 http://dx.doi.org/10.3390/diagnostics12020528 |
Ejemplares similares
-
Inter-reader agreement of (18)F-FDG PET/CT for the quantification of carotid artery plaque inflammation
por: Johnsrud, Kjersti, et al.
Publicado: (2020) -
(18)F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques
por: Johnsrud, Kjersti, et al.
Publicado: (2017) -
(64)Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
por: Mirzaei, Siroos, et al.
Publicado: (2019) -
The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19
por: Griffin, Matthew T., et al.
Publicado: (2023) -
FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)